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HIV-1 infection of human monocytes induces production
of prostaglandin E2 (PGE2) in vitro and in vivo, which
has capacity to make the bystander T cells unresponsive
(anergic). ICER, a potent transcriptional repressor
induced by PGE2 leads to transcriptional attenuation of
interleukin-2 (IL-2) and an induction of T cell suppres-
sion. We propose that this HIV-1 triggered mechanism
may subvert physiologically relevant suppression of IL-2
by regulatory CD4+CD25+ T (Treg) cells. Our preliminary
studies suggest that the suppressive mechanism conveyed
by Treg cells stems from coexpression of ICER and Foxp3,
which inhibits IL-2 expression. Moreover, naïve
CD4+CD25- responder T cells retrovirally transduced
with Foxp3 can induce the accumulation of ICER and
replace natural Treg cells. Importantly, ICER expression is
induced in activated responder T cells early and correlates
with a sharp decrease of IL-2 expression. Our preliminary
studies indicate that ICER inhibits HIV-1 LTR expression
and binds the cyclic responsive element (CRE)-like motifs
termed DSE positioned downstream of transcription initi-
ation site of HIV-1 LTR. Moreover, in monocytes PGE2
induced transcriptional attenuation of CCR5 expression
tightly correlates with upregulation of ICER. We conclude
that ICER is a critical component of Treg-mediated inhib-
itory function that affects transcriptional attenuation of
IL-2 production in T cells and that HIV-1 subverts this
mechanism via PGE2 and/or Tat-mediated induction of
ICER.
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